Antibiotic use and risk of colorectal cancer : a systematic review and dose-response meta-analysis
- Author
- Johanna Simin, Romina Fornes, Qing Liu, Renate Slind Olsen, Steven Callens (UGent) , Lars Engstrand and Nele Brusselaers (UGent)
- Organization
- Abstract
- Background It is understudied whether the posed association of oral antibiotics with colorectal cancer (CRC) varies between antibiotic spectrums, colorectal continuum, and if a non-linear dose-dependent relationship is present. Design Three electronic databases and a trial platform were searched for all relevant studies, from inception until February 2020, without restrictions. Random-effects meta-analyses provided pooled effect-sizes (ES) with 95% confidence intervals (CI). Dose-response analyses modelling the relationship between number of days exposed to antibiotics and CRC risk were extended to non-linear multivariable random-effects models. Results Of 6483 identified publications ten were eligible, including 4.1 million individuals and over 73,550 CRC cases. The pooled CRC risk was increased among individuals who ever-used antibiotics (ES = 1.17, 95%CI 1.05-1.30), particularly for broad-spectrum antibiotics (ES = 1.70, 95%CI 1.26-2.30), but not for narrow-spectrum antibiotic (ES = 1.11, 95% 0.93-1.32). The dose-response analysis did not provide strong evidence of any particular dose-response association, and the risk patterns were rather similar for colon and rectal cancer. Discussion The antibiotic use associated CRC risk seemingly differs between broad- and narrow-spectrum antibiotics, and possibly within the colorectal continuum. It remains unclear whether this association is causal, requiring more mechanistic studies and further clarification of drug-microbiome interactions.
- Keywords
- BREAST-CANCER, INFLAMMATION, MICROBIOME, INFECTION, EXPOSURE, BIAS
Downloads
-
Simin 2020 doseresponse MA antibiotics CRC.pdf
- full text (Published version)
- |
- open access
- |
- |
- 717.45 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8688795
- MLA
- Simin, Johanna, et al. “Antibiotic Use and Risk of Colorectal Cancer : A Systematic Review and Dose-Response Meta-Analysis.” BRITISH JOURNAL OF CANCER, vol. 123, no. 12, 2020, pp. 1825–32, doi:10.1038/s41416-020-01082-2.
- APA
- Simin, J., Fornes, R., Liu, Q., Olsen, R. S., Callens, S., Engstrand, L., & Brusselaers, N. (2020). Antibiotic use and risk of colorectal cancer : a systematic review and dose-response meta-analysis. BRITISH JOURNAL OF CANCER, 123(12), 1825–1832. https://doi.org/10.1038/s41416-020-01082-2
- Chicago author-date
- Simin, Johanna, Romina Fornes, Qing Liu, Renate Slind Olsen, Steven Callens, Lars Engstrand, and Nele Brusselaers. 2020. “Antibiotic Use and Risk of Colorectal Cancer : A Systematic Review and Dose-Response Meta-Analysis.” BRITISH JOURNAL OF CANCER 123 (12): 1825–32. https://doi.org/10.1038/s41416-020-01082-2.
- Chicago author-date (all authors)
- Simin, Johanna, Romina Fornes, Qing Liu, Renate Slind Olsen, Steven Callens, Lars Engstrand, and Nele Brusselaers. 2020. “Antibiotic Use and Risk of Colorectal Cancer : A Systematic Review and Dose-Response Meta-Analysis.” BRITISH JOURNAL OF CANCER 123 (12): 1825–1832. doi:10.1038/s41416-020-01082-2.
- Vancouver
- 1.Simin J, Fornes R, Liu Q, Olsen RS, Callens S, Engstrand L, et al. Antibiotic use and risk of colorectal cancer : a systematic review and dose-response meta-analysis. BRITISH JOURNAL OF CANCER. 2020;123(12):1825–32.
- IEEE
- [1]J. Simin et al., “Antibiotic use and risk of colorectal cancer : a systematic review and dose-response meta-analysis,” BRITISH JOURNAL OF CANCER, vol. 123, no. 12, pp. 1825–1832, 2020.
@article{8688795,
abstract = {{Background It is understudied whether the posed association of oral antibiotics with colorectal cancer (CRC) varies between antibiotic spectrums, colorectal continuum, and if a non-linear dose-dependent relationship is present. Design Three electronic databases and a trial platform were searched for all relevant studies, from inception until February 2020, without restrictions. Random-effects meta-analyses provided pooled effect-sizes (ES) with 95% confidence intervals (CI). Dose-response analyses modelling the relationship between number of days exposed to antibiotics and CRC risk were extended to non-linear multivariable random-effects models. Results Of 6483 identified publications ten were eligible, including 4.1 million individuals and over 73,550 CRC cases. The pooled CRC risk was increased among individuals who ever-used antibiotics (ES = 1.17, 95%CI 1.05-1.30), particularly for broad-spectrum antibiotics (ES = 1.70, 95%CI 1.26-2.30), but not for narrow-spectrum antibiotic (ES = 1.11, 95% 0.93-1.32). The dose-response analysis did not provide strong evidence of any particular dose-response association, and the risk patterns were rather similar for colon and rectal cancer. Discussion The antibiotic use associated CRC risk seemingly differs between broad- and narrow-spectrum antibiotics, and possibly within the colorectal continuum. It remains unclear whether this association is causal, requiring more mechanistic studies and further clarification of drug-microbiome interactions.}},
author = {{Simin, Johanna and Fornes, Romina and Liu, Qing and Olsen, Renate Slind and Callens, Steven and Engstrand, Lars and Brusselaers, Nele}},
issn = {{0007-0920}},
journal = {{BRITISH JOURNAL OF CANCER}},
keywords = {{BREAST-CANCER,INFLAMMATION,MICROBIOME,INFECTION,EXPOSURE,BIAS}},
language = {{eng}},
number = {{12}},
pages = {{1825--1832}},
title = {{Antibiotic use and risk of colorectal cancer : a systematic review and dose-response meta-analysis}},
url = {{http://doi.org/10.1038/s41416-020-01082-2}},
volume = {{123}},
year = {{2020}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: